Clinical trial
Development of Immune Globulin Treatment for Avian Flu
NCT00383071 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00383071 |
|---|---|
| Title | Development of Immune Globulin Treatment for Avian Flu |
| Official title | A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infectious Diseases, Influenza, Avian Flu |
| Intervention type | Biological, Procedure |
| Interventions | H5N1 vaccine, Apheresis |
| Enrollment | 126 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Dec 1, 2014 |
| First posted | Oct 2, 2006 |
| Last update posted | Jul 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: